Expression Pattern and Prognostic Utility of PME-1 in Patients with Hepatocellular Carcinoma

References

• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. doi:10.3322/caac.2134927253694
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–855. doi:10.1136/gutjnl-2013-30662724531850
   PubMed Web of Science ®Google Scholar
• Yabe R, Tsuji S, Mochida S, et al. A stable association with PME-1 may be dispensable for PP2A demethylation-implications for the detection of PP2A methylation and immunoprecipitation. FEBS Open Bio. 2018;8(9):1486–1496. doi:10.1002/2211-5463.12485
   PubMed Web of Science ®Google Scholar
• Ortega-Gutiérrez S, Leung D, Ficarro S, Peters EC, Cravatt BF. Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice. PLoS One. 2008;3(7):e2486. doi:10.1371/journal.pone.000248618596935
   PubMed Web of Science ®Google Scholar
• Yabe R, Miura A, Usui T, et al. Protein phosphatase methyl-esterase PME-1 protects protein phosphatase 2A from ubiquitin/proteasome degradation. PLoS One. 2015;10(12):e0145226. doi:10.1371/journal.pone.014522626678046
   PubMed Web of Science ®Google Scholar
• Park HJ, Lee KW, Oh S, et al. Protein phosphatase 2A and its methylation modulating enzymes LCMT-1 and PME-1 are dysregulated in tauopathies of progressive supranuclear palsy and Alzheimer disease. J Neuropathol Exp Neurol. 2018;77(2):139–148. doi:10.1093/jnen/nlx11029281045
   PubMed Web of Science ®Google Scholar
• Xia X, Gholkar A, Senese S, Torres JZ. A LCMT1-PME-1 methylation equilibrium controls mitotic spindle size. Cell Cycle. 2015;14(12):1938–1947. doi:10.1080/15384101.2015.102648725839665
   PubMed Web of Science ®Google Scholar
• Lipina C, Hundal HS. Carnosic acid stimulates glucose uptake in skeletal muscle cells via a PME-1/PP2A/PKB signalling axis. Cell Signal. 2014;26(11):2343–2349. doi:10.1016/j.cellsig.2014.07.02225038454
   PubMed Web of Science ®Google Scholar
• Sontag JM, Nunbhakdi-Craig V, Mitterhuber M, Ogris E, Sontag E. Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells. J Neurochem. 2010;115(6):1455–1465. doi:10.1111/j.1471-4159.2010.07049.x21044074
   PubMed Web of Science ®Google Scholar
• Kaur A, Westermarck J. Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1. Biochem Soc Trans. 2016;44(6):1683–1693. doi:10.1042/BST2016016127913678
   PubMedGoogle Scholar
• Puustinen P, Junttila MR, Vanhatupa S, et al. PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma. Cancer Res. 2009;69(7):2870–2877. doi:10.1158/0008-5472.CAN-08-276019293187
   PubMed Web of Science ®Google Scholar
• Wandzioch E, Pusey M, Werda A, et al. PME-1 modulates protein phosphatase 2A activity to promote the malignant phenotype of endometrial cancer cells. Cancer Res. 2014;74(16):4295–4305. doi:10.1158/0008-5472.CAN-13-313024928782
   PubMed Web of Science ®Google Scholar
• Li J, Han S, Qian Z, et al. Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target. Cancer Biol Ther. 2014;15(1):128–134. doi:10.4161/cbt.2714624253382
   PubMed Web of Science ®Google Scholar
• Hsieh YT, Chou MM, Chen HC, Tseng JJ. IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1. Gynecol Oncol. 2013;131(1):182–190. doi:10.1016/j.ygyno.2013.07.10623911878
   PubMed Web of Science ®Google Scholar
• Kaur A, Elzagheid A, Birkman EM, et al. Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer. Cancer Med. 2015;4(12):1798–1808. doi:10.1002/cam4.54126377365
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. doi:10.1038/nrdp.2016.1827158749
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Zhang S, Li J, Yin ZY, et al. Expression pattern and clinicopathologic significance of NKD1 in human primary hepatocellular carcinoma. APMIS. 2015;123(4):315–320. doi:10.1111/apm.1236025706354
   PubMed Web of Science ®Google Scholar
• Liu X, Chen S, Tu J, Cai W, Xu Q. HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma. Int J Mol Med. 2016;37(3):825–835. doi:10.3892/ijmm.2016.248226846697
   PubMed Web of Science ®Google Scholar
• Haynes HR, White P, Hares KM, et al. The transcription factor PPARα is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma. Histopathology. 2017;70(7):1030–1043. doi:10.1111/his.1314227926792
   PubMed Web of Science ®Google Scholar
• Goh GB, Chang PE, Tan CK. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):919–928. doi:10.1016/j.bpg.2015.09.00726651253
   PubMed Web of Science ®Google Scholar
• Jin N, Shi R, Jiang Y, et al. Glycogen synthase kinase-3β suppresses the expression of protein phosphatase methylesterase-1 through β-catenin. Aging (Albany NY). 2019;11(21):9672–9688. doi:10.18632/aging.10241331714894
   PubMedGoogle Scholar
• Sun J, Guo Y, Bie B, et al. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway. J Cell Biochem. 2020;121(1):443–457. doi:10.1002/jcb.2920631231887
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhou Z, Jin S, et al. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Sci. 2018;109(5):1414–1427. doi:10.1111/cas.1359829603830
   PubMed Web of Science ®Google Scholar
• Kaur A, Denisova OV, Qiao X, et al. PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells. Cancer Res. 2016;76(23):7001–7011. doi:10.1158/0008-5472.CAN-16-113427671680
   PubMed Web of Science ®Google Scholar
• Kim SY, Choi J, Lee DH, Park JH, Hwang YJ, Baek KH. PME-1 is regulated by USP36 in ERK and Akt signaling pathways. FEBS Lett. 2018;592(9):1575–1588. doi:10.1002/1873-3468.1303929577269
   PubMed Web of Science ®Google Scholar